Altimmune (ALT)
(Delayed Data from NSDQ)
$7.12 USD
-0.08 (-1.11%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $7.12 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 35% (87 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.58 | 9.99 |
Current Quarter Estimate | -0.36 | -1.06 | 61.00 |
Year Ago Quarter Estimate | -0.39 | -0.06 | 54.84 |
Next Quarter Estimate | -0.32 | -1.85 | 63.00 |
Next Year Estimate | -0.96 | 12.67 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 4.20 | 20.20 | 15.67 |
Next Year | 29.93 | 15.90 | 11.34 |
Last 5 Years | NA | 7.80 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -1.82 |
Price/Book (MRQ) | 3.31 | 1.65 |
Price/Cash Flow (MRFY) | NA | 8.75 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -24,778.97% | -58.89% |
Return on Equity (TTM) | -53.09% | -58.88% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.